Down 5% - couldn't see anything bad that was new - although it does look like guidance of about $167m might be a stretch???
I've rated it sell as I suspect SIBT will hit it harder than the market is factoring in, and the extra scrutiny of the sector after VET might costs some dollars.
Add to My Watchlist
What is My Watchlist?